NEWS

ocean medicines
Ocean Medicines “Kick-Off Meeting” | Silvia Lino and Nuno Leitão
Ocean Medicines is a network of academic, research centres and SMEs across Europe, with proven experience in higher education, training
Read more.
Sea4Us at Euromarine workshop | Silvia Lino and Nuno Leitão
Sea4Us was present at an Euromarine workshop in Naples, Italy, on the 4th and 5th of April, 2016. Euromarine is
Read more.
Sea4Us Interview with Expresso | Portugal 2020
Expresso journal interviewed Sea4Us while covering the stories of 20 companies that received funds from Portugal 2020. At the time, they
Read more.
11th Innovation Awards – Novo Banco: Sea4Us at the finals
The Sea4Us's project "From the Portuguese sea to the treatment of chronic pain" is one of the finalists of the
Read more.
Sea4Us at the Blue Business Forum | Blue Week Lisboa 2015
Sea4Us participated in the Blue Business Forum at Feira Internacional de Lisboa (FIL) on 4-6th June, 2015, in the framework
Read more.
Sea4Us at the Official Visit of the President of the Portuguese Republic to Norway – Business Delegation
Sea4Us was proudly represented by Pedro Lima (co-founder, CSO and CEO) at the Biomarine Resources Delegation, integrated in the official
Read more.
Sea4Us is a founding member of BLUEBIO ALLIANCE
Sea4Us is one of the founding members of BLUEBIO ALLIANCE, the new national platform about marine biotechnology and marine bioresources
Read more.
PROMAR funding approved!
Sea4Us's project "Aquaculture of marine organisms for the development of compounds with therapeutic activity" was approved by the Portuguese governmental
Read more.
Barlavento Journal Interview | Pedro Lima and Filipe Vilas-Boas
Sea4Us was interviewed by the Algarve regional newspaper “Jornal do Barlavento” ("Weekly Regional Algarve Newspaper"). This was published in October 2014. Page print. On-line version.
Read more.
10th Innovation Awards – Novo Banco: Sea4Us at the finals
The Sea4Us's project "New analgesic for the treatment of chronic pain has its origins in the Portuguese sea" is one
Read more.